Baxter is executing a portfolio simplification with the Kidney Care (Vantive) separation completing, leaving a focused medical products and pharmaceuticals business. Debt reduction from divestiture proceeds improves the balance sheet. Hurricane Helene IV fluid plant disruption has been resolved but margin recovery is gradual. Limited near-term catalysts beyond execution.
Thesis reviewed May 29, 2026
Baxter International Inc. is headquartered in United States, which is currently showing elevated risk signals.
🇺🇸United States82EXITView United States risk detail →🏥Healthcare33NEUTRAL| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| CVS | CVS Health Corporation | 40 | +15% | ↓3% | AVOID |
| HCA | HCA Healthcare Inc. | 40 | +9% | ↓3% | EARLY |
| UNH | UnitedHealth Group Inc. | 37 | +16% | ↓3% | AVOID |
| TMO | Thermo Fisher Scientific Inc. | 37 | +11% | ↓3% | EARLY |
| CI | The Cigna Group | 37 | +9% | ↓3% | NEUTRAL |
| ELV | Elevance Health Inc. | 37 | +7% | ↓3% | NEUTRAL |
| TEVA | Teva Pharmaceutical Industries Ltd. | 37 | +9% | ↓3% | NEUTRAL |
Investors who hold BAX may also have indirect exposure through these country funds.
Baxter completes Vantive Kidney Care spin transaction
North Cove plant returns to full IV fluid production
Estimates · Yahoo Finance · Not audited figures
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Debbie Wasserman SchultzFL | D | Buy | $1k–$15k | Nov 18, 24 | -41.0% |
| Earl BlumenauerOR | Buy | Unknown amount | Jul 9, 24 | -47.5% |